Home > Boards > US OTC > Medical - Equipment > Arrayit Corporation (ARYC)

1-2-18: Arrayit completes site visit and laboratory tour

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
StockDetective Member Profile
Member Level 
Followed By 124
Posts 6,332
Boards Moderated 5
Alias Born 12/08/16
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 7:52:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 7:32:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 7:09:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 6:52:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 6:30:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 6:11:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 5:47:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 5:14:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 4:44:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 4:19:42 PM
Arrayit Corporation Announces Allergy Testing Services Agreement with a Major Health and Wellness Provider GlobeNewswire Inc. - 12/3/2018 5:30:00 AM
Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health GlobeNewswire Inc. - 11/19/2018 5:30:00 AM
Arrayit Corporation Announces Brands Expansion of Proprietary Finger Stick Allergy Testing GlobeNewswire Inc. - 11/5/2018 5:30:00 AM
Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business GlobeNewswire Inc. - 11/1/2018 5:30:00 AM
Arrayit Corporation Launches Patient Data Solutions Allergy Testing Portal for Doctors and Clinics GlobeNewswire Inc. - 10/22/2018 5:30:00 AM
Arrayit Corporation Aces Three Consecutive Rounds of Proficiency Testing with the College of American Pathologists GlobeNewswire Inc. - 10/8/2018 5:30:00 AM
Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration GlobeNewswire Inc. - 9/24/2018 5:30:00 AM
Arrayit Corporation Approved for Direct Medicare Billing by the Centers for Medicare and Medicaid Services GlobeNewswire Inc. - 9/10/2018 5:30:00 AM
Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers GlobeNewswire Inc. - 8/27/2018 5:30:00 AM
Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain GlobeNewswire Inc. - 8/13/2018 5:30:00 AM
Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics GlobeNewswire Inc. - 7/30/2018 5:30:00 AM
Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration GlobeNewswire Inc. - 7/16/2018 5:30:00 AM
Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains GlobeNewswire Inc. - 7/2/2018 5:30:00 AM
Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network GlobeNewswire Inc. - 6/18/2018 5:30:00 AM
Arrayit Corporation Achieves Testing Accuracy Required for Medicare and Medicaid Reimbursement GlobeNewswire Inc. - 5/30/2018 8:30:00 AM
StockDetective Member Level  Saturday, 12/08/18 12:01:22 PM
Re: StockDetective post# 110228
Post # of 137023 
1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance https://www.fda.gov


Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.



Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration

Sunnyvale, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports the shipment of clinical instrumentation and quantification software to the United States Food and Drug Administration (FDA). Arrayit uses the same instrumentation and software to test for allergy and food intolerance as well as pipeline indications for ovarian cancer and Parkinson’s Disease (PD). Testing is performed in the company’s Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the California Department of Public Health (CDPH) and the Center for Medicare and Medicaid Services (CMS).

https://www.yahoo.com/amphtml/finance/news/arrayit-corporation-ships-clinical-instrumentation-093000351.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist